The role of fundamental research and biotechnology in finding solutions to the global problem of antibiotic resistance

Clinical Infectious Diseases

Volumn 24, Issue 1 SUPPL., 1997, Pages

  Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; RECOMBINANT PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOTECHNOLOGY; DRUG RESEARCH; HUMAN; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BIOTECHNOLOGY; DRUG INDUSTRY; DRUG RESISTANCE, MICROBIAL; PHARMACOLOGY, CLINICAL; WORLD HEALTH;

EID: 0031021241     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.supplement_1.s148     Document Type: Article

References (14)

1. Silver L, Bostian K. Screening of natural products for antimicrobial agents. Eur J Clin Microbiol Infect Dis 1990;9:455-61.
2. Neu HC. Infection problems for the 1990s - do we have an answer? Scand J Infect Dis Suppl 1993;91:7-13.
3. Travis J. Reviving the antibiotic miracle. Science 1994;264:360-2.
4. Hancock REW, McCurry TE. Canadian Bacterial Diseases Network: a new approach to university-industry relationships. Clin Invest Med 1993;16:306-13.
5. Armstrong GD, Rowe PC, Goodyer D, et al. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome. J Infect Dis 1995;171:1042-5.
6. Hancock REW, Falla TJ. Antimicrobial peptides: broad spectrum antibiotics from nature. Clin Microbiol Infect 1989;1:226-9.
7. Famsworth NR. Ethnopharmacology and drug development. Ciba Found Symp 1994;185:42-51.
8. Seydel JK. Modern strategies in the design of antimicrobial agents. In: Jackson CG, Schlumberger HD, Zeiler HJ, eds. Perspectives in amiinfective therapy. Braunschweig, Germany: Vieweg and Sohn, 1989:21-8.
9. Blondelle SE, Takahashi E, Houghten RA, Perez-Paya E. Rapid identification of compounds with enhanced antimicrobial activity by using conformationally defined combinatorial libraries. Biochem J 1996;313:141-7.
10. Dougan G. Molecular characterization of bacterial virulence factors and the consequences for vaccine design. J Gen Microbiol 1989;135:1397-406.
11. Roilides E, Pizzo PA. Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin Infect Dis 1992;15:508-24.
12. Livermore DM. Determinants of activity of β-lactamase inhibitor combinations. J Antimicrob Chemother 1993;31(suppl A):9-21.
13. Piers KL, Brown MH, Hancock REW. Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene 1993;134:7-13.
14. Piers KL, Brown MH, Hancock REW. Improvement of outer membrane-permeabilization and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob Agents Chemother 1994;38:2311-6.